GRIFOLS | GRF - Cash And Equivalent

Stock Price
9.21
Daily Change
0.003 0.03%
Monthly
-7.21%
Yearly
14.77%
Q2 Forecast
8.94

GRIFOLS reported EUR558.69M in Cash and Equivalent for its fiscal quarter ending in June of 2025.





Cash And Equivalent Change Date
Alcon AG USD 1.5B 90M Sep/2025
Almirall EUR 337.77M 14.83M Dec/2025
Amadeus IT EUR 968.2M 525.2M Sep/2025
Amarin USD 122.8M 25.08M Sep/2025
argenx SE USD 4.3B 2.21B Sep/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
Bayer EUR 5.9B 1.34B Sep/2025
Cie Automotive EUR 486.62M 9.22M Dec/2024
Demant DKK 1.33B 188M Dec/2025
Ence Energia y Celulosa EUR 249.6M 19.18M Sep/2025
Essilor EUR 2.79B 535M Jun/2025
Ferrovial EUR 4.24B 1.41B Dec/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.58B 326.57M Dec/2025
Galapagos EUR 87.87M 23.41M Dec/2025
Genmab DKK 1.72B 46M Dec/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Inditex EUR 5.28B 675M Dec/2025
Merck EUR 2.25B 1.08B Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
Philips EUR 1.91B 90M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
UCB EUR 1.57B 1.14B Dec/2024
Viscofan EUR 46.53M 24.9M Jun/2025